ADENOSQUAMOUS CELL LUNG CANCER

ADENOSQUAMOUS CELL LUNG CANCER was reported 48 times

These drug classes are most commonly taken by patients reporting ADENOSQUAMOUS CELL LUNG CANCER:

# Drug Count
0 Tumor Necrosis Factor Blocker [EPC] 8
1 Thalidomide Analog [EPC] 7
2 Corticosteroid [EPC] 6
3 Alkylating Drug [EPC] 5
4 Nonsteroidal Anti-inflammatory Drug [EPC] 5
5 Proton Pump Inhibitor [EPC] 5
6 Kinase Inhibitor [EPC] 4
7 RANK Ligand Inhibitor [EPC] 4
8 Endothelin Receptor Antagonist [EPC] 3
9 Phosphodiesterase 5 Inhibitor [EPC] 3
10 Platinum-based Drug [EPC] 3
11 Azole Antifungal [EPC] 2
12 Janus Kinase Inhibitor [EPC] 2
13 Platelet Aggregation Inhibitor [EPC] 2
14 Programmed Death Receptor-1 Blocking Antibody [EPC] 2
15 5-alpha Reductase Inhibitor [EPC] 1
16 Amide Local Anesthetic [EPC] 1
17 Aminosalicylate [EPC] 1
18 Androgen Receptor Inhibitor [EPC] 1
19 Anti-IgE [EPC] 1
20 Antiarrhythmic [EPC] 1
21 Antirheumatic Agent [EPC] 1
22 Benzodiazepine [EPC] 1
23 Cholinergic Muscarinic Antagonist [EPC] 1
24 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
25 Ester Local Anesthetic [EPC] 1
26 Folate Analog Metabolic Inhibitor [EPC] 1
27 HMG-CoA Reductase Inhibitor [EPC] 1
28 Histamine-2 Receptor Antagonist [EPC] 1
29 Insulin Analog [EPC] 1
30 Interleukin-23 Antagonist [EPC] 1
31 Microtubule Inhibitor [EPC] 1
32 Nitroimidazole Antimicrobial [EPC] 1
33 Non-Standardized Chemical Allergen [EPC] 1
34 Opioid Agonist [EPC] 1
35 Parathyroid Hormone Analog [EPC] 1
36 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
37 Provitamin D2 Compound [EPC] 1
38 Sulfonylurea [EPC] 1
39 Vitamin B12 [EPC] 1
40 Vitamin C [EPC] 1
41 Vitamin D [EPC] 1
42 Xanthine Oxidase Inhibitor [EPC] 1